Yingqin Li - Search Results

Year	Number of Results
2012	2
2013	2
2014	4
2015	13
2016	8
2017	8
2018	11
2019	11
2020	18
2021	13
2022	12
2023	6
2024	4

1

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.

Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, Jin F, Shi M, Chen YP, Hu WH, Cheng ZB, Wang SY, Tian Y, Wang XC, Sun Y, Li JG, Li WF, Li YH, Tang LL, Mao YP, Zhou GQ, Sun R, Liu X, Guo R, Long GX, Liang SQ, Li L, Huang J, Long JH, Zang J, Liu QD, Zou L, Su QF, Zheng BM, Xiao Y, Guo Y, Han F, Mo HY, Lv JW, Du XJ, Xu C, Liu N, Li YQ, Chua MLK, Xie FY, Sun Y, Ma J. Zhang Y, et al. N Engl J Med. 2019 Sep 19;381(12):1124-1135. doi: 10.1056/NEJMoa1905287. Epub 2019 May 31. N Engl J Med. 2019. PMID: 31150573 Clinical Trial.

2

TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models.

Li JY, Zhao Y, Gong S, Wang MM, Liu X, He QM, Li YQ, Huang SY, Qiao H, Tan XR, Ye ML, Zhu XH, He SW, Li Q, Liang YL, Chen KL, Huang SW, Li QJ, Ma J, Liu N. Li JY, et al. Nat Commun. 2023 Feb 16;14(1):865. doi: 10.1038/s41467-023-36523-y. Nat Commun. 2023. PMID: 36797289 Free PMC article.

3

Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma.

Chen YP, Yin JH, Li WF, Li HJ, Chen DP, Zhang CJ, Lv JW, Wang YQ, Li XM, Li JY, Zhang PP, Li YQ, He QM, Yang XJ, Lei Y, Tang LL, Zhou GQ, Mao YP, Wei C, Xiong KX, Zhang HB, Zhu SD, Hou Y, Sun Y, Dean M, Amit I, Wu K, Kuang DM, Li GB, Liu N, Ma J. Chen YP, et al. Cell Res. 2020 Nov;30(11):1024-1042. doi: 10.1038/s41422-020-0374-x. Epub 2020 Jul 20. Cell Res. 2020. PMID: 32686767 Free PMC article.

4

Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China.

Qiao H, Tan XR, Li H, Li JY, Chen XZ, Li YQ, Li WF, Tang LL, Zhou GQ, Zhang Y, Liang YL, He QM, Zhao Y, Huang SY, Gong S, Li Q, Ye ML, Chen KL, Sun Y, Ma J, Liu N. Qiao H, et al. JAMA Oncol. 2022 Sep 1;8(9):1301-1309. doi: 10.1001/jamaoncol.2022.2810. JAMA Oncol. 2022. PMID: 35834269 Free PMC article.

5

USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma.

Chen Y, Zhao Y, Yang X, Ren X, Huang S, Gong S, Tan X, Li J, He S, Li Y, Hong X, Li Q, Ding C, Fang X, Ma J, Liu N. Chen Y, et al. Among authors: li y. Nat Commun. 2022 Jan 25;13(1):501. doi: 10.1038/s41467-022-28158-2. Nat Commun. 2022. PMID: 35079021 Free PMC article.

6

Chemotherapy-Induced Senescence Reprogramming Promotes Nasopharyngeal Carcinoma Metastasis by circRNA-Mediated PKR Activation.

Li Q, Zhao YH, Xu C, Liang YL, Zhao Y, He QM, Li JY, Chen KL, Qiao H, Liu N, Ma J, Chen L, Li YQ. Li Q, et al. Adv Sci (Weinh). 2023 Mar;10(8):e2205668. doi: 10.1002/advs.202205668. Epub 2023 Jan 22. Adv Sci (Weinh). 2023. PMID: 36683218 Free PMC article.

7

WTAP-mediated m⁶A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis.

Li ZX, Zheng ZQ, Yang PY, Lin L, Zhou GQ, Lv JW, Zhang LL, Chen F, Li YQ, Wu CF, Li F, Ma J, Liu N, Sun Y. Li ZX, et al. Cell Death Differ. 2022 Jun;29(6):1137-1151. doi: 10.1038/s41418-021-00905-w. Epub 2022 Jan 8. Cell Death Differ. 2022. PMID: 34999731 Free PMC article.

8

CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization.

Hong X, Li Q, Li J, Chen K, He Q, Zhao Y, Liang Y, Zhao Y, Qiao H, Liu N, Ma J, Li Y. Hong X, et al. Among authors: li y. Clin Cancer Res. 2022 Oct 14;28(20):4521-4535. doi: 10.1158/1078-0432.CCR-22-0991. Clin Cancer Res. 2022. PMID: 35917517

9

Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.

Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, Jin F, Shi M, Chen YP, Hu WH, Cheng ZB, Wang SY, Tian Y, Wang XC, Sun Y, Li JG, Li WF, Li YH, Mao YP, Zhou GQ, Sun R, Liu X, Guo R, Long GX, Liang SQ, Li L, Huang J, Long JH, Zang J, Liu QD, Zou L, Su QF, Zheng BM, Xiao Y, Guo Y, Han F, Mo HY, Lv JW, Du XJ, Xu C, Liu N, Li YQ, Xie FY, Sun Y, Ma J, Tang LL. Zhang Y, et al. J Clin Oncol. 2022 Aug 1;40(22):2420-2425. doi: 10.1200/JCO.22.00327. Epub 2022 Jun 16. J Clin Oncol. 2022. PMID: 35709465 Clinical Trial.

10

N⁶ -Methyladenosine-Modified CBX1 Regulates Nasopharyngeal Carcinoma Progression Through Heterochromatin Formation and STAT1 Activation.

Zhao Y, Huang S, Tan X, Long L, He Q, Liang X, Bai J, Li Q, Lin J, Li Y, Liu N, Ma J, Chen Y. Zhao Y, et al. Among authors: li y. Adv Sci (Weinh). 2022 Dec;9(36):e2205091. doi: 10.1002/advs.202205091. Epub 2022 Oct 30. Adv Sci (Weinh). 2022. PMID: 36310139 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year